These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 31273375

  • 1. Population pharmacokinetics of piperacillin in febrile children receiving cancer chemotherapy: the impact of body weight and target on an optimal dosing regimen.
    Thorsted A, Kristoffersson AN, Maarbjerg SF, Schrøder H, Wang M, Brock B, Nielsen EI, Friberg LE.
    J Antimicrob Chemother; 2019 Oct 01; 74(10):2984-2993. PubMed ID: 31273375
    [Abstract] [Full Text] [Related]

  • 2. Continuous infusion of piperacillin-tazobactam significantly improves target attainment in children with cancer and fever.
    Maarbjerg SF, Thorsted A, Friberg LE, Nielsen EI, Wang M, Schrøder H, Albertsen BK.
    Cancer Rep (Hoboken); 2022 Oct 01; 5(10):e1585. PubMed ID: 34796702
    [Abstract] [Full Text] [Related]

  • 3. Piperacillin pharmacokinetics and target attainment in children with cancer and fever: Can we optimize our dosing strategy?
    Maarbjerg SF, Thorsted A, Kristoffersson A, Friberg LE, Nielsen EI, Wang M, Brock B, Schrøder H.
    Pediatr Blood Cancer; 2019 Jun 01; 66(6):e27654. PubMed ID: 30740885
    [Abstract] [Full Text] [Related]

  • 4. Population pharmacokinetics of the piperacillin component of piperacillin/tazobactam in pediatric oncology patients with fever and neutropenia.
    Cies JJ, Jain J, Kuti JL.
    Pediatr Blood Cancer; 2015 Mar 01; 62(3):477-82. PubMed ID: 25328131
    [Abstract] [Full Text] [Related]

  • 5. Parameters influencing the pharmacokinetics/pharmacodynamics of piperacillin/tazobactam in patients with febrile neutropenia and haematological malignancy: a prospective study.
    Benech N, Dumitrescu O, Conrad A, Balsat M, Paubelle E, Ducastelle-Lepretre S, Labussière-Wallet H, Salles G, Cohen S, Goutelle S, Ader F, Lyon HEMINF Study Group.
    J Antimicrob Chemother; 2019 Sep 01; 74(9):2676-2680. PubMed ID: 31219562
    [Abstract] [Full Text] [Related]

  • 6. Using Population Pharmacokinetic Modeling and Monte Carlo Simulations To Determine whether Standard Doses of Piperacillin in Piperacillin-Tazobactam Regimens Are Adequate for the Management of Febrile Neutropenia.
    Sime FB, Hahn U, Warner MS, Tiong IS, Roberts MS, Lipman J, Peake SL, Roberts JA.
    Antimicrob Agents Chemother; 2017 Nov 01; 61(11):. PubMed ID: 28807922
    [Abstract] [Full Text] [Related]

  • 7. Population pharmacokinetics of piperacillin/tazobactam in critically ill young children.
    Cies JJ, Shankar V, Schlichting C, Kuti JL.
    Pediatr Infect Dis J; 2014 Feb 01; 33(2):168-73. PubMed ID: 23907263
    [Abstract] [Full Text] [Related]

  • 8. Piperacillin Population Pharmacokinetics and Dosing Regimen Optimization in Critically Ill Children with Normal and Augmented Renal Clearance.
    Béranger A, Benaboud S, Urien S, Moulin F, Bille E, Lesage F, Zheng Y, Genuini M, Gana I, Renolleau S, Hirt D, Tréluyer JM, Oualha M.
    Clin Pharmacokinet; 2019 Feb 01; 58(2):223-233. PubMed ID: 29862466
    [Abstract] [Full Text] [Related]

  • 9. Population Pharmacokinetics and Safety of Piperacillin-Tazobactam Extended Infusions in Infants and Children.
    Thibault C, Lavigne J, Litalien C, Kassir N, Théorêt Y, Autmizguine J.
    Antimicrob Agents Chemother; 2019 Nov 01; 63(11):. PubMed ID: 31427292
    [Abstract] [Full Text] [Related]

  • 10. Piperacillin Population Pharmacokinetics in Critically Ill Adults During Sustained Low-Efficiency Dialysis.
    Kanji S, Roberts JA, Xie J, Alobaid A, Zelenitsky S, Hiremath S, Zhang G, Watpool I, Porteous R, Patel R.
    Ann Pharmacother; 2018 Oct 01; 52(10):965-973. PubMed ID: 29730948
    [Abstract] [Full Text] [Related]

  • 11. Population Pharmacokinetics and Pharmacodynamics of Extended-Infusion Piperacillin and Tazobactam in Critically Ill Children.
    Nichols K, Chung EK, Knoderer CA, Buenger LE, Healy DP, Dees J, Crumby AS, Kays MB.
    Antimicrob Agents Chemother; 2016 Jan 01; 60(1):522-31. PubMed ID: 26552978
    [Abstract] [Full Text] [Related]

  • 12. Population Pharmacokinetics and Dosing Optimization of Piperacillin-Tazobactam in Critically Ill Patients on Extracorporeal Membrane Oxygenation and the Influence of Concomitant Renal Replacement Therapy.
    Hahn J, Min KL, Kang S, Yang S, Park MS, Wi J, Chang MJ.
    Microbiol Spectr; 2021 Dec 22; 9(3):e0063321. PubMed ID: 34937189
    [Abstract] [Full Text] [Related]

  • 13. Population pharmacokinetics of piperacillin/tazobactam in critically ill Korean patients and the effects of extracorporeal membrane oxygenation.
    Kim YK, Kim HS, Park S, Kim HI, Lee SH, Lee DH.
    J Antimicrob Chemother; 2022 Apr 27; 77(5):1353-1364. PubMed ID: 35224630
    [Abstract] [Full Text] [Related]

  • 14. Comparative pharmacodynamics of intermittent and prolonged infusions of piperacillin/tazobactam using Monte Carlo simulations and steady-state pharmacokinetic data from hospitalized patients.
    Shea KM, Cheatham SC, Smith DW, Wack MF, Sowinski KM, Kays MB.
    Ann Pharmacother; 2009 Nov 27; 43(11):1747-54. PubMed ID: 19809009
    [Abstract] [Full Text] [Related]

  • 15. Towards optimizing cefepime/tazobactam (WCK 4282) exposure to achieve efficacy against piperacillin/tazobactam-resistant ESBL infections: dose recommendations for various renal functions, including intermittent haemodialysis, in healthy individuals.
    Muller AE, De Winter BCM, Koch BCP.
    J Antimicrob Chemother; 2024 May 02; 79(5):1093-1100. PubMed ID: 38507250
    [Abstract] [Full Text] [Related]

  • 16. After standard dosage of piperacillin plasma concentrations of drug are subtherapeutic in burn patients.
    Olbrisch K, Kisch T, Thern J, Kramme E, Rupp J, Graf T, Wicha SG, Mailänder P, Raasch W.
    Naunyn Schmiedebergs Arch Pharmacol; 2019 Feb 02; 392(2):229-241. PubMed ID: 30368548
    [Abstract] [Full Text] [Related]

  • 17. Optimizing Piperacillin Dosing in Pediatric Liver Transplant Recipients: A Case Series.
    Morales Junior R, Hosawi A, Tang Girdwood S, Dong M, Juodinis VA, Romano P, Ebner PAR, Duarte NJC, de Souza DC, Santos SRCJ.
    Pediatr Transplant; 2024 Nov 02; 28(7):e14860. PubMed ID: 39319995
    [Abstract] [Full Text] [Related]

  • 18. OTAC: Optimization of Antibiotic Therapy in Critically ill Patients. Using beta-lactam antibiotics by continuous infusion.
    Esteve-Pitarch E, Padullés-Zamora A, Maisterra-Santos K, Colom-Codina H, Cobo-Sacristán S.
    Farm Hosp; 2019 Sep 01; 43(5):151-157. PubMed ID: 31469627
    [Abstract] [Full Text] [Related]

  • 19. Pharmacokinetics and Pharmacodynamics of Extended Infusion Versus Short Infusion Piperacillin-Tazobactam in Critically Ill Patients Undergoing CRRT.
    Shotwell MS, Nesbitt R, Madonia PN, Gould ER, Connor MJ, Salem C, Aduroja OA, Amde M, Groszek JJ, Wei P, Taylor ME, Tolwani AJ, Fissell WH.
    Clin J Am Soc Nephrol; 2016 Aug 08; 11(8):1377-1383. PubMed ID: 27197907
    [Abstract] [Full Text] [Related]

  • 20. First-dose and steady-state population pharmacokinetics and pharmacodynamics of piperacillin by continuous or intermittent dosing in critically ill patients with sepsis.
    Roberts JA, Kirkpatrick CM, Roberts MS, Dalley AJ, Lipman J.
    Int J Antimicrob Agents; 2010 Feb 08; 35(2):156-63. PubMed ID: 20018492
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.